gene editing
| 7 min read
Creative solutions may enable gene therapy for more common diseases.
| 6 min read
Recent advancements in mitochondrial genome editing technologies take scientists one step closer to developing viable treatments for mitochondrial diseases, which affect 1 in 4300 adults.
| 1 min read
Researchers are using CRISPR gene editing to restore function of the mutant protein that causes Duchenne muscular dystrophy, a genetic disease that causes muscle degeneration.
Available on Demand
LIVE October 25th, 2021 at 1:00 PM ET
Delivering CRISPR cargo in vivo to treat disease-causing DNA mutations
Delivering CRISPR cargo in vivo to treat disease-causing DNA mutations
| 6 min read
CRISPR gene editing directly and indirectly drives advances in cardiovascular disease therapeutic development.
| 5 min read
A native Hawaiian, anthropologist, and genome scientist, Keolu Fox investigates how mutations found in indigenous populations contribute to human health and emphasizes the importance of considering who benefits from research involving indigenous genomes.
Available on Demand
LIVE July 28th, 2021 at 2:30 PM ET
In this webinar, experts will discuss cytosine and adenosine base-editors to introduce point mutations in DNA strands without creating a breakpoint, and opportunities and considerations for using them.
In this webinar, experts will discuss cytosine and adenosine base-editors to introduce point mutations in DNA strands without creating a breakpoint, and opportunities and considerations for using them.
| 4 min read
The arguments over "first to invent" and ownership of CRISPR tech continue
| 2 min read
Pair announces research collaboration leveraging eGenesis’ genome engineering and transgenic production capabilities to conduct in-vivo testing of pancreatic islet cell xenotransplants
